Chemotherapy may be more effective in highly proliferative ovarian carcinomas—A translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol)

This publication has 19 references indexed in Scilit:

• The Impact of C-kit and Ki-67 Expression on Patients Prognosis in Advanced Ovarian Serous Carcinoma
  International Journal of Gynecological Pathology, 2005
• Transforming growth factor-β3 protection of epithelial cells from cycle-selective chemotherapy in vitro
  Biochemical Pharmacology, 1997
• Ki67 Antigen Immunostaining (MIB 1 Monoclonal Antibody) in Serous Ovarian Tumors: Index of Proliferative Activity with Prognostic Significance
  Gynecologic Oncology, 1995
• Brief, high‐temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues
  The Journal of Pathology, 1994
• Steroid receptors and Ki‐67 reactivity in ovarian cancer and in normal ovary: Correlation with dna flow cytometry, biochemical receptor assay, and patient survival
  The Journal of Pathology, 1990
• Taxol: A Novel Investigational Antimicrotubule Agent
  JNCI Journal of the National Cancer Institute, 1990
• Immunohistochemical determination of tumour growth fraction in human ovarian carcinoma
  BJOG: An International Journal of Obstetrics and Gynaecology, 1989
• Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).
  Journal of Histochemistry & Cytochemistry, 1984
• The use of avidin-biotin interaction in immunoenzymatic techniques.
  Journal of Histochemistry & Cytochemistry, 1979
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958